[PDF] Top 20 Profile of Xeomin<sup>®</sup> (incobotulinumtoxinA) for the treatment of blepharospasm
Has 10000 "Profile of Xeomin<sup>®</sup> (incobotulinumtoxinA) for the treatment of blepharospasm" found on our website. Below are the top 20 most common "Profile of Xeomin<sup>®</sup> (incobotulinumtoxinA) for the treatment of blepharospasm".
Profile of Xeomin<sup>®</sup> (incobotulinumtoxinA) for the treatment of blepharospasm
... (incobotulinumtoxinA), a unique botulinum neurotoxin type A (BoNT/A) drug free of complexing proteins otherwise contained in all conventional BoNT/A drugs, was recently approved by US Food and Drug Administration for the ... See full document
8
A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin<sup>®</sup>), a botulinum neurotoxin type A free from complexing proteins
... toxin treatment has been challenged by preclinical and clinical studies with ...event profile similar to that of ...the treatment of CD and BSP, and may pose a lower risk for immunogenicity leading ... See full document
13
The lung function profile of once-daily tiotropium and olodaterol via Respimat<sup>®</sup> is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler<sup>®</sup> (ENERGITO<sup>®</sup> study)<div><br /></div>
... maintenance treatment with the goal of improving lung function, with associated symptomatic and health-status benefits, tiotropium + olodaterol should be considered as another treatment option that offers ... See full document
13
Comparison of outcomes of conventional WaveLight<sup>®</sup> Allegretto Wave<sup>®</sup> and Technolas<sup>®</sup> excimer lasers in myopic laser in situ keratomileusis
... guided) treatment mode, all available in combination with an optional dynamic rotational eye ...Gaussian profile, with treat- ment delivered at 50 ...reducing treatment power by up to 10%–15% for ... See full document
10
Baracle<sup>®</sup> vs Baraclude<sup>®</sup> for 48 weeks in patients with treatment-naïve chronic hepatitis B: a comparison of efficacy and safety
... A major concern regarding generic antiviral agent for HBV infection would be whether it can show bioequivalence, comparable efficacy, and safety in real patients. First, ETV from Dong-A ST demonstrated an equivalent ... See full document
8
Tiotropium HandiHaler<sup>®</sup> in the treatment of COPD: A safety review
... the treatment of COPD with numerous published randomized, double-blind, controlled clinical trials showing improvements in airflow, air trapping, hyper- inflation, symptoms such as breathlessness (as measured by ... See full document
13
<p>Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO<sup>®</sup> and OTEMTO<sup>®</sup> studies: a subgroup analysis by age</p>
... This analysis shows that the combination of once-daily tiotropium + olodaterol demonstrated significant improve- ments from baseline for lung function and symptomatic response in all groups, which were improved versus ... See full document
10
<p>TearCare<sup>®</sup> system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare<sup>®</sup> treatment on subjects with dry eye disease</p>
... the compress may be too cool initially or may cool off too quickly. On the other hand, a compress that is too warm may cause injury to the eyelid or even the eye. Also, the surface of the warm compress may have a ... See full document
10
Inhaled human insulin (Exubera<sup>®</sup>): clinical profile and patient considerations
... offer treatment and quality of life benefits to patients with diabetes, which are achieved through the delivery of a systemic dose of insulin via the pulmonary route while fulfilling the appropriate ... See full document
10
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX<sup>®</sup> mesalamine
... Adherence to treatment schedules with mesalamine remains an issue in practice. MMX mesalamine provides a higher per-pill dose of mesalamine than other mesalamine formu- lations, allowing for once-daily dosing. The ... See full document
10
Developments in administration of growth hormone treatment: focus on Norditropin<sup>®</sup> Flexpro<sup>®</sup>
... 00596037), treatment with LB03002 for 26 or 52 weeks in adults with growth hormone deficiency demonstrated a sustained reduction of fat mass and other body composition parameters, with a good safety profile ... See full document
8
The NordiNet<sup>®</sup> International Outcome Study and NovoNet<sup>®</sup> ANSWER Program<sup>®</sup>: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin<sup>®</sup>)
... a treatment intervention, yet important to disease ...risk profile of treatments and can help in the detection of rare side effects and treatment ... See full document
9
Central aortic blood pressure and augmentation index: comparison between Vasotens<sup>®</sup> and SphygmoCor<sup>®</sup> technology
... Central aortic systolic blood pressure (aSBP) and augmen- tation index (aAIx) were obtained by means of applanation tonometry and the oscillometric method was compared.. Results: aSBP [r] ... See full document
7
An echo to Choosing Wisely<sup>®</sup> in Switzerland
... This analysis was conducted in the Department of Internal Medicine at Uster Hospital, a secondary care hospital in the Canton of Zurich, Switzerland. The Department of Internal Medicine provides about 100 beds and treats ... See full document
8
Aterofisiol<sup>®</sup> in carotid plaque evolution
... one tablet of Aterofisiol every 24 hours or one tablet of Cardioaspirin + one tablet of placebo every 24 hours. Each treatment was started 30 days before the surgery and was stopped 5 days before the surgery. The ... See full document
8
<p>An integrated safety analysis of combined acetaminophen and ibuprofen (Maxigesic<sup>®</sup>/ Combogesic<sup>®</sup>) in adults</p>
... The term “study drug” here refers to either APAP, IBP, FDCs, or placebo. The term “baseline” is defined as the value obtained immediately prior to administration of the study drug. Any change from baseline is defined as ... See full document
14
An update on TroVax<sup>®</sup> for the treatment of progressive castration-resistant prostate cancer
... clinical trial. The immune response surrogate was established as a linear combination of baseline 5T4-specific antibody titers, hemoglobin level, and hematocrit, which were the only variables to remain statistically ... See full document
9
<p>Solutol<sup>®</sup>HS15+pluronicF127 and Solutol<sup>®</sup>HS15+pluronicL61 mixed micelle systems for oral delivery of genistein</p>
... Two oral drug delivery systems based on HS15+F127 and HS15+L61 binary mixed micelles were developed to markedly enhance the solubility and oral absorption of GEN. In this study, the orga[r] ... See full document
10
A placebo-controlled, double-blind clinical trial to evaluate the efficacy of Imedeen<sup>®</sup> Time Perfection<sup>®</sup> for improving the appearance of photodamaged skin
... Results: Seventy-four subjects with primarily Fitzpatrick skin type III (78%–79%) and Glogau type III (53%–58%) completed the study (Imedeen: n=36; placebo: n=38). The mean difference in change from baseline to week 12 ... See full document
8
Results from a global survey of contact lens-wearer satisfaction with OPTI-FREE<sup>®</sup> PureMoist<sup>®</sup> Multi-Purpose Disinfecting Solution
... Eligible volunteers were provided with trial solution (OPTI-FREE PureMoist MPDS), a new pair of lenses, a new Alcon green and white screw-top lens case, and the follow-up survey in t[r] ... See full document
8
Related subjects